Discontinued — last reported Q1 '24
Medtronic Japan Australia New Zealand Korea Canadaand Western Europe — Net Sales increased by 8.2% to $2.68B in Q1 2024 compared to the prior quarter. Year-over-year, this metric grew by 1.7%, from $2.63B to $2.68B. Over 3 years (FY 2021 to FY 2024), Japan Australia New Zealand Korea Canadaand Western Europe — Net Sales shows relatively stable performance with a 0.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful product adoption and competitive strength in mature international healthcare markets, while a decrease may signal pricing pressure, regulatory hurdles, or loss of market share to local competitors.
This metric represents the total revenue generated from the sale of medical devices and therapeutic solutions within est...
Peers in the medical device industry typically report similar geographic revenue splits, often categorized as 'International' or 'EMEA/APAC' developed markets, allowing for benchmarking of global market penetration.
mdt_segment_non_u_s_developed_markets_net_sales| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.67B | $2.60B | $2.48B | $2.44B | $2.61B | $2.33B | $2.16B | $2.29B | $2.63B | $2.46B | $2.37B | $2.47B | $2.68B |
| QoQ Change | — | -2.7% | -4.7% | -1.6% | +7.0% | -10.8% | -7.3% | +6.4% | +14.6% | -6.3% | -3.9% | +4.4% | +8.2% |
| YoY Change | — | — | — | — | -2.4% | -10.5% | -13.0% | -5.9% | +0.8% | +5.8% | +9.8% | +7.8% | +1.7% |